News
Anthem Biosciences Ltd, a CRDMO founded in 2006, offers end-to-end drug discovery-to-manufacturing services and specialises ...
Since this IPO was fully an OFS, the contract research, development and manufacturing company will not receive any funds, ...
Anthem Biosciences' IPO ended on 16 July, with the issue booked over 60 times. Strong demand from qualified institutional ...
Anthem Biosciences IPO closes today; check GMP, latest subscription stats, and key dates -act now before bidding ends!
Anthem Biosciences IPO GMP surged on Wednesday as the Rs 3,395-crore initial share saw robust subscription on the concluding ...
Check latest subscription status, grey market premium (GMP), allotment date, listing date, and other key details here ...
Anthem Biosciences IPO oversubscribed 63.86 times, attracting strong QIB support, raising ₹1,016 crore from anchor investors.
Anthem Biosciences' Rs 3,395 crore IPO was subscribed 63.86 times, exceeding expectations. QIBs showed strong interest, while ...
Anthem Biosciences is raising ₹3,395 crore through an initial share sale, which comprises of entirely an offer-for-sale by ...
Today is the last day for investors to subscribe for the Anthem Biosciences IPO, which so far has gathered a lot of attention ...
Anthem Biosciences Ltd's IPO was subscribed 63.86 times by closing day, driven by institutional buyers. The Rs 3,395-crore ...
Anthem Biosciences' IPO is seeing huge demand on its last day. The issue has been subscribed 1,400% so far, showing strong interest from all types of investors. At the same time, the GMP has jumped to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results